Kindrachuk Jason, Falcinelli Shane, Wada Jiro, Kuhn Jens H, Hensley Lisa E, Jahrling Peter B
Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.
Pathog Dis. 2014 Jul;71(2):190-98. doi: 10.1111/2049-632X.12163. Epub 2014 Apr 10.
Currently, there is a paucity of information regarding the molecular pathogenesis for many high-consequence pathogens (HCPs) that pose threats to both national and international public health. In spite of this, investigations of the molecular pathogenesis for many HCPs have been limited to gross pathological changes in animal models or global analysis of gene expression. Further, questions remain regarding the ability of animal models of disease to recapitulate human molecular pathogenesis or act as predictors of therapeutic efficacy. Thus, it is likely that medical countermeasure development for HCPs will rely on identifying therapeutic targets that are uniquely modulated during HCP infection. It is also appreciated that many cellular processes can be regulated independently of changes in transcription or translation through phosphorylation events. Cellular kinases, individually or collectively (the kinome), play critical roles in regulating complex biology, underlie various malignancies, and represent high-priority drug targets. The growing interest in kinases in both basic and translational research has driven efforts to develop technologies that enable characterization of phosphorylation-mediated signal transduction. To this end, enhanced technical capabilities at the IRF-Frederick provide the unique capability for characterizing host responses to HCP insult during the course of infection and identify novel targets for therapeutic intervention.
目前,对于许多对国家和国际公共卫生构成威胁的高后果病原体(HCP),有关其分子发病机制的信息匮乏。尽管如此,对许多HCP分子发病机制的研究仅限于动物模型中的大体病理变化或基因表达的全局分析。此外,关于疾病动物模型重现人类分子发病机制或作为治疗效果预测指标的能力,仍然存在疑问。因此,HCP的医学对策开发可能将依赖于识别在HCP感染期间被独特调节的治疗靶点。还应认识到,许多细胞过程可通过磷酸化事件独立于转录或翻译变化进行调节。细胞激酶单独或共同作用(激酶组),在调节复杂生物学过程中起关键作用,是各种恶性肿瘤的基础,也是高度优先的药物靶点。基础研究和转化研究对激酶的兴趣日益浓厚,推动了开发能够表征磷酸化介导的信号转导技术的努力。为此,IRF-弗雷德里克(IRF-Frederick)增强的技术能力为在感染过程中表征宿主对HCP损伤的反应以及识别治疗干预的新靶点提供了独特能力。